Bristol-Myers Squibb Co.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | $7.13B | $15.69B | $6.29B |
| FY2016 | $5.72B | $14.55B | $2.64B |
| FY2017 | $7.24B | $14.54B | $3.91B |
| FY2018 | $5.78B | $12.91B | $5.34B |
| FY2019 | $5.64B | $15.32B | $7.34B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | $7.13B | $15.69B | $6.29B |
| FY2016 | $5.72B | $14.55B | $2.64B |
| FY2017 | $7.24B | $14.54B | $3.91B |
| FY2018 | $5.78B | $12.91B | $5.34B |
| FY2019 | $5.64B | $15.32B | $7.34B |